Effect of the brain stimulation with very weak electrical current in opiod addiction

Transcranial direct current stimulation effects on the treatment of the opiate addiction in Ultra rapid opioid detoxification method

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015022821273N1

Enrollment

Registered

2015-04-04

Start date

2015-03-08

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

opiod addiction. Drug abuse counselling and surveillance

Interventions

Intervention 1: intervention group:We will apply real mode of tDCS once a day for three successive sessions. anodal electrode will locate on the right dorsolateral prefrontal cortex(DLPFC) and catho

Treatment - Devices

intervention group:We will apply real mode of tDCS once a day for three successive sessions. anodal electrode will locate on the right dorsolateral prefrontal cortex(DLPFC) and cathode on the left o

control group:We will apply sham mode of tDCS once a day for three successive sessions. anodal electrode will locate on the right dorsolateral prefrontal cortex(DLPFC) and cathode on the left one.Sin

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Inclusion criteria:Diagnostic criteria for opiate dependence defined by Diagnostic and Statistical Manual of Mental Disorders (4th ed.) (DSM-IV); Inhalational application route;Literate; last usage at the night before;male gender Exclusion criteria: Siezure or any history of convulsion which has been prohibited for tDCS;Cardiopulmomary or Hepatic diease or any sensitivity to anesthetics which have been prohibited for general anesthesia; Comorbidy of other psychiatric disorders such as psychosis,anxiety,mood and affective disorder;Amphetamine,Alcohol and sedatives abuse

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Craving. Timepoint: before,afte rand 1,3,12hrs and 2weeks,1,3months after treatment. Method of measurement: DDQ questionary.;Withdrawal syndrom. Timepoint: before,afte rand 1,3,12hrs and 2weeks,1,3months after treatment. Method of measurement: OOWS questionary.;Relapse. Timepoint: 2 weeks,1 & 3 months after treatment. Method of measurement: Interviews & Urine strip test.	—

Secondary

Measure	Time frame
Irritation of electrode location. Timepoint: after the last intervention. Method of measurement: observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Mirhosseini

Yazd University of Medical Sciences

mirhosseini@tabrizu.ac.ir mirhoseini.h@gmail.com+98 35 3624 5956

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026